))
United Against Infection: Conquering sepsis and AMR with Pfizer UK Senior Medical Advisor and GP Tom Ashfield
Manage episode 375622513 series 3456428
Sisällön tarjoaa media@sepsistrust.org. media@sepsistrust.org tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In episode 5 of Sepsis Voices with Dr Ron, UKST’s Founder & Joint CEO Dr Ron Daniels is joined by Dr Tom Ashfield a Senior Medical Advisor at Pfizer, and a GP. Tom is an employee of Pfizer UK, his contributions reflect the work of Pfizer UK in AMR and his own experience as a doctor. Pfizer UK have undertaken content approval of this episode.
The two doctors discuss the threat of antimicrobial resistance (AMR), and the link to sepsis. They also explore the vital work of the Infection Management Coalition to put responsible antimicrobial stewardship on the agenda of global health leaders, as well as making the issue easy to understand so that patients are empowered to safeguard their own future.
The pair cover:
- What AMR is and how sepsis is regarded by the World Health Organization as the final common pathway to death from most untreatable infections
- Public knowledge of AMR and what can be done to improve awareness
- How UKST’s work has influenced Tom’s practice as a GP
- Changes to community care following Covid-19 pandemic and impact on patients
- Improving the way diagnostics are integrated into clinical settings
- Tom’s experience in the pharmaceutical industry and the need for collaboration through initiatives like the Infection Management Coalition
Find out more about the Infection Management Coalition: https://theimc.org/
Find out more about sepsis, and the work of the UKST: https://sepsistrust.org/
Final approval undertaken by Pfizer UK. Date of prep. August 2023; PP-UNP-GBR-6068
17 jaksoa
Jaa
